Open AccessTreatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF study
Author(s) -
Wen Yu Lin,
Fa Po Chung,
ChiaTe Liao,
Jin Long Huang,
Huai Wen Liang,
YingHsiang Lee,
Pei-Ying Lin,
WeiRu Chiou,
Chien Yi Hsu,
Hsuan Chang
Publication year - 2021
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000578
Subject(s) - medicine , ejection fraction , heart failure , valsartan , sacubitril , cardiology , ace inhibitor , angiotensin receptor , blood pressure , diabetes mellitus , angiotensin ii , angiotensin converting enzyme , endocrinology
This study used a real-world database to investigate the prescription patterns of sacubitril/valsartan (Sac/Val) among Taiwanese patients with heart failure with reduced ejection fraction (HFrEF).